Clinical Trials on Ocular Melanoma
Total 8567 results
-
Pain TherapeuticsCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMelanoma (Skin)
-
Peking UniversityNovartisCompletedMetastatic MelanomaChina
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)No longer available
-
Charite University, Berlin, GermanyUnknown
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
SentoClone ABUnknownMalignant MelanomaSweden
-
Royal Marsden NHS Foundation TrustUnknown
-
University of TurkuCompletedMetastatic MelanomaFinland
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedStage IV Uveal Melanoma | Stage IIIA Uveal Melanoma | Stage IIIB Uveal Melanoma | Stage IIIC Uveal MelanomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IV Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIIA Intraocular Melanoma | Stage IIIB Intraocular Melanoma | Stage...United States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage III Melanoma | Extraocular Extension MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage IV Skin Melanoma | Recurrent MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Skin Melanoma | Recurrent MelanomaUnited States
-
Eisai Inc.TerminatedUnresectable Stage III Melanoma | Wild Type BRAF Stage IV MelanomaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent MelanomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IA Skin Melanoma | Stage IB Skin MelanomaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IA Skin Melanoma | Stage IB Skin MelanomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterWithdrawnSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaMelanoma | Recurrent Melanoma | Stage IV Melanoma | Stage III Melanoma
-
Medical University of GrazBristol-Myers SquibbTerminatedMalignant Melanoma Stage III | Malignant Melanoma Stage IV | Fecal Microbiota TransplantationAustria
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Metastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIIA Skin MelanomaUnited States
-
National Cancer Institute (NCI)CompletedCiliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Extraocular Extension MelanomaUnited States
-
Replimune Inc.Not yet recruiting
-
Hull University Teaching Hospitals NHS TrustNot yet recruiting
-
University Hospital, Basel, SwitzerlandAnaveon AGRecruiting
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Institut Jean-GodinotUniversité de Reims Champagne-ArdenneNot yet recruiting
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCNot yet recruitingMucosal MelanomaAustralia
-
Henan Cancer HospitalRecruitingAdvanced MelanomaChina
-
Eucure (Beijing) Biopharma Co., LtdRecruiting
-
Memorial Sloan Kettering Cancer CenterPfizerRecruiting
-
Peking University Cancer Hospital & InstituteRecruiting
-
First Affiliated Hospital of Zhejiang UniversityRecruiting
-
John KirkwoodBristol-Myers Squibb; Secura Bio, Inc.RecruitingUnresectable MelanomaUnited States
-
Fudan UniversityRecruitingMalignant MelanomaChina
-
Peking University Cancer Hospital & InstituteRecruitingMucosal MelanomaChina
-
Miltenyi Biomedicine GmbHDLR German Aerospace CenterRecruiting
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)RecruitingMetastatic MelanomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteRecruiting
-
ImmVira Pharma Co. LtdSuspendedMelanoma | Malignant MelanomaUnited States
-
Institut CurieCompleted
-
University of ChicagoMerck Sharp & Dohme LLC; Evelo Biosciences, Inc.Suspended
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic MelanomaMetastatic MelanomaUnited States